Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study. (BARI-COVID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04320277
Recruitment Status : Not yet recruiting
First Posted : March 24, 2020
Last Update Posted : April 22, 2020
Sponsor:
Information provided by (Responsible Party):
Fabrizio Cantini, Hospital of Prato

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : July 30, 2020
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):